Related Experiment Videos
Laboratory evaluations of erectile dysfunction: an evidence based approach
Joshua Bodie1, Jean Lewis, Doug Schow
1University of Minnesota and the VA Health Care System, Minneapolis, Minnesota, USA.
The Journal of Urology
|May 29, 2003
Summary
Many men with erectile dysfunction have abnormal lab results, including low testosterone and high cholesterol. Standardized lab screening can identify risk factors for better treatment outcomes.
Area of Science:
- Endocrinology
- Urology
- Internal Medicine
Background:
- Erectile dysfunction (ED) is a common condition affecting men's health.
- Identifying underlying causes of ED is crucial for effective management.
- Laboratory abnormalities are frequently associated with ED.
Purpose of the Study:
- To determine the prevalence of laboratory abnormalities in men undergoing initial evaluation for erectile dysfunction.
- To assess common laboratory screening tests for ED.
Main Methods:
- Retrospective review of computerized charts from 1987 to 2002.
- Analysis of laboratory data for 3,547 men with ED.
- Evaluation of testosterone, prolactin, LH, TSH, HbA1c, PSA, hemoglobin, cholesterol, and creatinine levels.
Main Results:
- 18.7% had low testosterone, 4.6% increased prolactin, 14.6% abnormal LH, 4.0% increased TSH, 8.3% increased PSA, 26.5% anemia, 11.9% renal insufficiency.
- High prevalence of elevated hemoglobin A1c (52.9%) and total serum cholesterol (48.4%) in ED patients.
Conclusions:
- An evidence-based, standardized approach to laboratory evaluation for ED is recommended.
- Laboratory screening should identify risk factors amenable to lifestyle changes or pharmacological intervention.
- Targeted screening can improve patient outcomes and management strategies.